848 related articles for article (PubMed ID: 8810912)
41. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
Sakamoto Y; Yoshida M; Semba K; Hunter T
Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
[TBL] [Abstract][Full Text] [Related]
42. DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers.
Laity JH; Dyson HJ; Wright PE
J Mol Biol; 2000 Jan; 295(4):719-27. PubMed ID: 10656784
[TBL] [Abstract][Full Text] [Related]
43. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
Iben S; Royer-Pokora B
Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
[TBL] [Abstract][Full Text] [Related]
44. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.
Bruening W; Bardeesy N; Silverman BL; Cohn RA; Machin GA; Aronson AJ; Housman D; Pelletier J
Nat Genet; 1992 May; 1(2):144-8. PubMed ID: 1302008
[TBL] [Abstract][Full Text] [Related]
45. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
[TBL] [Abstract][Full Text] [Related]
46. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
[TBL] [Abstract][Full Text] [Related]
47. Sequence of the WT1 upstream region including the Wit-1 gene.
Gessler M; Bruns GA
Genomics; 1993 Aug; 17(2):499-501. PubMed ID: 8406502
[TBL] [Abstract][Full Text] [Related]
48. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
49. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
[TBL] [Abstract][Full Text] [Related]
50. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
[TBL] [Abstract][Full Text] [Related]
51. Functional properties of WT1.
Haber DA; Englert C; Maheswaran S
Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
[TBL] [Abstract][Full Text] [Related]
52. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
Deuel TF; Guan LS; Wang ZY
Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
[TBL] [Abstract][Full Text] [Related]
53. Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1.
Kim JM; Hong Y; Semba K; Kim S
Biochem Biophys Res Commun; 2000 Jan; 267(1):59-63. PubMed ID: 10623574
[TBL] [Abstract][Full Text] [Related]
54. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
55. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.
Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614
[TBL] [Abstract][Full Text] [Related]
56. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
57. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
Nordenskjöld A; Friedman E; Anvret M
Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
[TBL] [Abstract][Full Text] [Related]
58. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
[TBL] [Abstract][Full Text] [Related]
59. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
Hewitt SM; Saunders GF
Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
[TBL] [Abstract][Full Text] [Related]
60. Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome.
Chiang PW; Aliaga S; Travers S; Spector E; Tsai AC
Curr Opin Pediatr; 2008 Feb; 20(1):103-6. PubMed ID: 18197048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
